In the dynamic world of pharmaceutical research and development, the availability of high-quality chemical intermediates is paramount. Boc-O-Methyl-D-serine, identified by its CAS number 86123-95-7, is a prime example of such a critical compound. Its unique chiral structure and functional groups make it an indispensable building block, particularly in the synthesis of advanced pharmaceutical agents like Lacosamide, an important medication for managing epilepsy.

For pharmaceutical companies, the journey from initial research to large-scale manufacturing involves sourcing reliable intermediates. Boc-O-Methyl-D-serine, characterized as a colorless to light yellow oily liquid with a purity typically exceeding 98.0%, requires meticulous quality control. Research scientists rely on these precise specifications to ensure the success and reproducibility of their experiments and synthetic pathways.

Procurement managers face the challenge of identifying suppliers who can consistently deliver this intermediate at a competitive price, especially for bulk requirements. Manufacturers in China are often a preferred source due to their significant production capacities and cost efficiencies. When looking to buy Boc-O-Methyl-D-serine, it is essential to partner with a manufacturer that understands the stringent quality demands of the pharmaceutical industry.

The chemical name Boc-O-Methyl-D-serine and its CAS number 86123-95-7 are globally recognized identifiers. Establishing a relationship with a trusted supplier ensures not only the quality of the product but also the security of the supply chain, which is vital for uninterrupted manufacturing operations. Access to detailed product information, including Certificates of Analysis, further solidifies the credibility of the supplier.

In essence, Boc-O-Methyl-D-serine is more than just a chemical; it's an enabler of innovation in the pharmaceutical sector. Its role in Lacosamide synthesis highlights the importance of specialized chiral intermediates. By prioritizing quality sourcing from reliable manufacturers, pharmaceutical companies can effectively advance their R&D efforts and ensure the efficient, high-volume production of essential medicines.